Moderator: Alan Hutson, PhD – Roswell Park Comprehensive Cancer Center
Webinar Description: Earlier cancer diagnosis, as well as rapid determination of tumor response after treatment, could lead to enhanced immunotherapy patient outcomes. Multimodal AI that can accept various data inputs, especially as treatments become more personalized, are prime for helping facilitate advances in cancer diagnosis and response classification. This webinar will describe current efforts in the development of multimodal AI for these purposes, with a specific focus on how these models can better serve immunotherapy clinical decision making.